Australia-listed medtech firm Artrya has disclosed that its subsidiary in the United States has signed a clinical partnership with Alabama-based Huntsville Heart Center.
According to a media release, an initial agreement between the companies involves a study to determine the efficacy of Artrya's AI technology for diagnosing coronary heart disease.
WHY IT MATTERS
The Artrya Salix is an AI-powered...
Medical technology firm Artrya has been cleared by the Australian government to commercialise an AI tool that diagnoses coronary heart disease. It has partnered with Perth-based radiology practice Envision Medical Imaging to market the product by early next year.
WHAT IT'S ABOUT
The AI tool,Salix, has been developed through the collaboration of researchers from the University of Western Australia...
A team of researchers at the University of Western Australia is coming up with an artificial intelligence-based risk assessment tool to better detect plaque in heart computed tomography scans.
WHY IT MATTERS
The research team comprising AI and cardiac imaging experts was recently awarded a grant worth AU$896,606 (about $695,000) from the government's Medical Research Future Fund to develop a tool...
A study recently published in Heart found that coronary heart disease (CHD) patients assigned a smartphone app for medication reminders demonstrated greater adherence than those who did not.
The investigation was conducted by a group of Australian researchers, and included a sample of 163 adults participants with an average age of roughly 58 years. Presented this week at the European Society of...
Yesterday, Redwood City, California-based HeartFlow, a company that specializes in creating computerized heart models to treat coronary diseases, announced that it landed $240 million in series E funding led by Wellington Management Company and Baillie Gifford & Company.
“This financing will enable us to drive commercial success of the HeartFlow Analysis, which is poised to become the global...
A relatively large randomized control trial in Australia has shown that a text messaging program can improve not only health behaviors, but actually affect health outcomes. The 2-year study of 710 patients with coronary heart disease, published in the Journal of the American Medical Association showed that six months of a text messaging intervention produced significant reduction in cholesterol,...
